Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 16

    1.

    Effects of tadalafil on myocardial blood flow in patients with coronary artery disease.

    Weinsaft JW, Hickey K, Bokhari S, Shahzad A, Bedding A, Costigan TM, Warner MR, Emmick JT, Bergmann SR.

    Coron Artery Dis. 2006 Sep;17(6):493-9.PMID: 16905960 [PubMed - indexed for MEDLINE]Related articles

    2.

    Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: a randomized, double-blind, parallel, placebo-controlled clinical study.

    Chen KK, Jiann BP, Lin JS, Lee SS, Huang ST, Wang CJ, Ju-Ton H, Su CK, Costigan TM, Emmick JT.

    J Sex Med. 2004 Sep;1(2):201-8. Erratum in: J Sex Med. 2005 Jan;2(1):158. PMID: 16422975 [PubMed - indexed for MEDLINE]Related articles

    3.

    Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events.

    Jackson G, Kloner RA, Costigan TM, Warner MR, Emmick JT.

    J Sex Med. 2004 Sep;1(2):161-7.PMID: 16422970 [PubMed - indexed for MEDLINE]Related articles

    4.

    The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval.

    Beasley CM Jr, Mitchell MI, Dmitrienko AA, Emmick JT, Shen W, Costigan TM, Bedding AW, Turik MA, Bakhtyari A, Warner MR, Ruskin JN, Cantilena LR Jr, Kloner RA.

    J Am Coll Cardiol. 2005 Aug 16;46(4):678-87.PMID: 16098435 [PubMed - indexed for MEDLINE]Related articles

    5.

    Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men.

    Kloner RA, Jackson G, Emmick JT, Mitchell MI, Bedding A, Warner MR, Pereira A.

    J Urol. 2004 Nov;172(5 Pt 1):1935-40.PMID: 15540759 [PubMed - indexed for MEDLINE]Related articles

    6.

    Absence of clinically important HERG channel blockade by three compounds that inhibit phosphodiesterase 5--sildenafil, tadalafil, and vardenafil.

    Dustan Sarazan R, Crumb WJ Jr, Beasley CM Jr, Emmick JT, Ferguson KM, Strnat CA, Sausen PJ.

    Eur J Pharmacol. 2004 Oct 19;502(3):163-7.PMID: 15476742 [PubMed - indexed for MEDLINE]Related articles

    7.

    A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil.

    von Keitz A, Rajfer J, Segal S, Murphy A, Denne J, Costigan T, Lockhart D, Beasley CM Jr, Emmick JT.

    Eur Urol. 2004 Apr;45(4):499-507; discussion 507-9.PMID: 15041116 [PubMed - indexed for MEDLINE]Related articles

    8.

    Time course of the interaction between tadalafil and nitrates.

    Kloner RA, Hutter AM, Emmick JT, Mitchell MI, Denne J, Jackson G.

    J Am Coll Cardiol. 2003 Nov 19;42(10):1855-60.PMID: 14642699 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cardiovascular effects of tadalafil in patients on common antihypertensive therapies.

    Kloner RA, Mitchell M, Emmick JT.

    Am J Cardiol. 2003 Nov 6;92(9A):47M-57M. Review.PMID: 14609623 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cardiovascular effects of tadalafil.

    Kloner RA, Mitchell M, Emmick JT.

    Am J Cardiol. 2003 Nov 6;92(9A):37M-46M. Review.PMID: 14609622 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of tadalafil on erectile dysfunction in men with diabetes.

    Sáenz de Tejada I, Anglin G, Knight JR, Emmick JT.

    Diabetes Care. 2002 Dec;25(12):2159-64.PMID: 12453954 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    High affinity C10-Oeq ester derivatives of ryanodine. Activator-selective agonists of the sarcoplasmic reticulum calcium release channel.

    Humerickhouse RA, Bidasee KR, Gerzon K, Emmick JT, Kwon S, Sutko JL, Ruest L, Besch HR Jr.

    J Biol Chem. 1994 Dec 2;269(48):30243-53.PMID: 7982934 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Dual effect of suramin on calcium fluxes across sarcoplasmic reticulum vesicle membranes.

    Emmick JT, Kwon S, Bidasee KR, Besch KT, Besch HR Jr.

    J Pharmacol Exp Ther. 1994 May;269(2):717-24.PMID: 8182538 [PubMed - indexed for MEDLINE]Related articles

    14.

    Differential activating and deactivating effects of natural ryanodine congeners on the calcium release channel of sarcoplasmic reticulum: evidence for separation of effects at functionally distinct sites.

    Humerickhouse RA, Besch HR Jr, Gerzon K, Ruest L, Sutko JL, Emmick JT.

    Mol Pharmacol. 1993 Aug;44(2):412-21.PMID: 8394996 [PubMed - indexed for MEDLINE]Related articles

    15.

    Amino- and guanidinoacylryanodines: basic ryanodine esters with enhanced affinity for the sarcoplasmic reticulum Ca(2+)-release channel.

    Gerzon K, Humerickhouse RA, Besch HR Jr, Bidasee KR, Emmick JT, Roeske RW, Tian Z, Ruest L, Sutko JL.

    J Med Chem. 1993 May 14;36(10):1319-23.PMID: 8388466 [PubMed - indexed for MEDLINE]Related articles

    16.

    Aging and vasodilation to atrial peptides.

    Emmick JT, Cohen ML.

    Clin Exp Hypertens A. 1986;8(1):75-90.PMID: 3011322 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...